![]() |
|
![]() |
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
Stony Brook University |
Information provided by: | Stony Brook University |
ClinicalTrials.gov Identifier: | NCT00552448 |
Asthma is a disease resulting in mucus hypersecretion and airways obstruction. This causes difficulty breathing. The High Frequency Chest Compressor (HFCC) is a device that has been shown to decrease respiratory complications in individuals with severe disability who are unable to clear airway secretions. There is a lack of studies using this device in children with asthma. The device has been shown in a study to be safe in children with asthma. We propose that using this device in our pediatric patients hospitalized in the pediatric ICU with asthma will result in decreased pediatric ICU stay. We will also look at asthma severity, total days of hospital stay and chest discomfort while on therapy.
Condition | Intervention |
Status Asthmaticus, Pediatric |
Device: High Frequency Chest Compression VEST |
MedlinePlus related topics: | Asthma |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Parallel Assignment, Efficacy Study |
Official Title: | Use of High Frequency Chest Compression (HFCC) in Pediatric Status Asthmaticus |
Estimated Enrollment: | 37 |
Study Start Date: | October 2007 |
Estimated Study Completion Date: | October 2008 |
Arms | Assigned Interventions |
1: Experimental
Use of the HFCC device in addition to standard therapy for status asthmaticus. The use of HFCC will not affect the therapy received
|
Device: High Frequency Chest Compression VEST
every 6 hours for 20 minutes
|
2: No Intervention
This group will not use the VEST or HFCC. They will just have standard therapy for status asthmaticus. The standard therapy will not be affected if they are in this group.
|
![]() |
Show Detailed Description |
Ages Eligible for Study: | 2 Years to 21 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Absolute contraindication to VEST use:
Presence of anomalies such as:
Contact: Adaobi C Kanu, MD | 631 444 8340 | akanu@notes.cc.sunysb.edu |
Contact: Kimberly Tafuri, MD | 631 444 2710 | ktafuri@notes.cc.sunysb.edu |
United States, New York | |||||
Stony Brook University Medical Center | Recruiting | ||||
Stony Brook, New York, United States, 11794 |
Stony Brook University |
Principal Investigator: | Adaobi C Kanu | Stony Brook University Hospital |
Study ID Numbers: | 20076812 |
First Received: | November 1, 2007 |
Last Updated: | November 1, 2007 |
ClinicalTrials.gov Identifier: | NCT00552448 |
Health Authority: | United States: Institutional Review Board |
|
|
|
|
![]() |